CTRI/2019/05/019105招募中未知
Integrating Pharmacogenomic and Population Pharmacokinetic Analysis for Precision Therapy of Isoniazid in TB Patients.
evin Thomas0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patients diagnosed with TB.
- •2. Patients who are under minimum three days of Isoniazid therapy.
- •3. Age more than 18 years and less than 70 years.
- •4. Patients who are willing to give informed consent.
排除标准
- •1. Vulnerable patients: Pregnant women and mentally challenged patients.
- •2. HIV positive patients.
研究者
相似试验
尚未招募
不适用
Treatment with Tapentadol in Cancer PatientsCTRI/2020/11/029206Manipal Academy of Higher Education
尚未招募
不适用
Impact of Genetic factors on Tacrolimus dosingCTRI/2020/06/025498Manipal College of Pharmaceutical Sciences
尚未招募
Unknown
Drug levels of Mycophenolic acid and the genetic mutations that affects these blood levels in patients with autoimmune diseases taking durg mycophenolate mofetil (MMF)CTRI/2023/03/050985Seth GS Medical College and KEM Hospital
招募中
不适用
Study of factors (including genetic factors) influencing the levels of tacrolimus in blood before and after intake in renal transplant patientsCTRI/2013/08/003871Jawaharlal Institute of Post Graduate Medical Education and Research JIPMER30
进行中（未招募）
不适用
APPLICATION OF PHARMACOGENOMICS IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER - PHARMACOGENOMICS IN THE ELDERLYELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCERMedDRA version: 6.1Level: HLTClassification code 10010040EUCTR2006-004016-40-ITAZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI